Related Experiment Video
Updated: Jan 21, 2026
06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
1.3K
Metabolic cardiomyopathy in pediatrics.
Victoria E Tril1, Alla V Burlutskaya1, Lily V Polischuk1
1Federal State Budgetary Educational Institution of Higher Education "Kuban State Medical University" The Ministry of Health of the Russian Federation, 4, Sedina Str., Krasnodar, Russia, 350063.
Reviews in Cardiovascular Medicine
|July 27, 2019
Summary
Cardiomyopathy is a growing concern in children, often progressing despite treatment. Early diagnosis and modern therapies are crucial for improving outcomes in pediatric cardiomyopathy cases.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Pathology
- Genetic Medicine
Background:
- Increasing incidence of non-specific myocardial lesions in children and adolescents.
- Cardiomyopathies represent a significant challenge in pediatric cardiovascular disease.
- These conditions are characterized by progressive nature and poor therapeutic response.
Purpose of the Study:
- To review current international data on cardiomyopathy diagnostics in children.
- To address terminology and classification of pediatric cardiomyopathies.
- To outline primary diagnostic criteria and modern management strategies.
Main Methods:
- Systematic review of international publications.
- Analysis of diagnostic criteria for non-coronary myocardial pathology.
- Evaluation of current pharmacotherapy approaches.
Main Results:
- Significant increase in non-specific myocardial lesions of non-inflammatory origin.
- Cardiomyopathies present a complex diagnostic and therapeutic challenge in pediatric patients.
- International classifications and diagnostic criteria are evolving.
Conclusions:
- Accurate diagnosis of pediatric cardiomyopathy is essential for effective management.
- Modern diagnostic methods and pharmacotherapy offer improved, though often challenging, treatment options.
- Further research into etiology and treatment is warranted for better prognosis.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
196
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196
01:30Cardiomyopathy II: Dilated Cardiomyopathy
490
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
490
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
486
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
486
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
426
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
426
00:52What is Metabolism?
131.2K
Overview
131.2K
01:25Cardiomyopathy I: Introduction and Classification
520
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
520